Marché mondial du traitement de la candidose vaginale – Tendances et prévisions de l'industrie jusqu'en 2028

Analyse et perspectives du marché : marché mondial du traitement de la candidose vaginale

Le marché du traitement de la candidose vaginale devrait connaître une croissance du marché au cours de la période de prévision 2021-2028. Data Bridge Market Research analyse le marché pour une croissance à un TCAC de 5,7 % au cours de la période de prévision mentionnée ci-dessus.

La candidose vaginale est une infection fongique causée par un type de champignon appelé Candida. Elle vit généralement dans différentes parties du corps, comme la bouche, le vagin, la gorge, l'intestin et la peau. Cette affection se caractérise par des pertes vaginales anormales, des démangeaisons vaginales, des douleurs pendant les rapports sexuels, des douleurs pendant la miction et des rougeurs. On l'appelle également infection vaginale à levures, candidose vulvo-vaginale ou vaginite candidosique.

L'augmentation de la prévalence de la candidose vaginale et la consommation inutile d'antibiotiques sont les principaux facteurs qui influencent le taux de croissance du marché. En outre, l'augmentation des dépenses de santé , l'incidence croissante de l'obésité et du diabète, l'augmentation du financement public et les initiatives croissantes des organisations gouvernementales et privées pour faire connaître la maladie et ses mesures préventives sont les facteurs qui vont développer le marché du traitement de la candidose vaginale.

L’augmentation des activités de recherche et développement et des marchés émergents offrira des opportunités bénéfiques pour le marché du traitement de la candidose vaginale au cours de la période de prévision 2021-2028.

Cependant, le coût élevé du traitement et les effets secondaires associés au traitement sont les facteurs qui entraveront la croissance du marché. Le manque de sensibilisation et les complications liées à la maladie, telles que la candidose invasive, constitueront un défi supplémentaire pour le marché du traitement de la candidose vaginale au cours de la période de prévision mentionnée ci-dessus.

This vaginal candidiasis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vaginal candidiasis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Vaginal Candidiasis Treatment Market Scope and Market Size

The vaginal candidiasis treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the vaginal candidiasis treatment market is segmented into antifungal drugs and others. Antifungal drugs have been further sub-segmented into clotrimazole, butoconazole, terconazole, miconazole and tioconazole.
• On the basis of diagnosis, the vaginal candidiasis treatment market is segmented into pelvic exam, vaginal secretion test and others.
• On the basis of dosage, the vaginal candidiasis treatment market is segmented into tablet, injection and others.
• On the basis of route of administration, the vaginal candidiasis treatment market is segmented into oral, intravenous and others.
• On the basis of symptoms, the vaginal candidiasis treatment market is segmented into abnormal vaginal discharge, vaginal itching, pain during sexual intercourse, pain while urinating and others.
• On the basis of end-users, the vaginal candidiasis treatment market is segmented into clinic, hospital and others.

The vaginal candidiasis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Vaginal Candidiasis Treatment Market Country Level Analysis

Vaginal candidiasis treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel as referenced above.

The countries covered in the vaginal candidiasis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the vaginal candidiasis treatment market due to the presence of major key players, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Vaginal candidiasis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Vaginal Candidiasis Treatment Market Share Analysis

Vaginal candidiasis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global vaginal candidiasis treatment market research.

Français Les principaux acteurs couverts dans le rapport sur le marché du traitement de la candidose vaginale sont Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Sun Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Glenmark Pharmaceuticals Limited, Abbott, Astellas Pharma Inc., Gilead Sciences, Inc., Enzon Pharmaceuticals, Inc., SCYNEXIS, Inc., Merck KGaA, Leadiant Biosciences, Inc., Bausch Health Companies Inc., Beckman Coulter, Inc., Basilea Pharmaceutica Ltd., Agilent Technologies, Inc., entre autres acteurs nationaux et mondiaux. Les données sur les parts de marché sont disponibles séparément pour le monde, l'Amérique du Nord, l'Europe, l'Asie-Pacifique (APAC), le Moyen-Orient et l'Afrique (MEA) et l'Amérique du Sud. Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.

SKU-66873